Goette, Andreas
Mollenhauer, Martin
Rudolph, Volker
Lamparter, Mathias
Meier, Martin
Böhm, Michael
Article History
Received: 11 April 2023
Accepted: 18 April 2023
First Online: 4 May 2023
Declarations
:
: A. Goette: EU Grant Horizon 2020 MAESTRIA Consortium; grant number 965286. Speaker fees von Abbott, Astra Zeneca, Bayer Health Care, Berlin Chemie, Biotronik, Boehringer Ingelheim, BMS/Pfizer, Boston Scientific, Daiichi-Sankyo, Medtronic, und Omeicos. M. Böhm is supported by the Deutsche Forschungsgemeinschaft (German Research Foundation; TTR 219, project number 322900939) and reports personal fees from Abbott, Amgen, Astra Zeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Cytokinetics, Medtronic, Novartis, ReCor, Servier and Vifor during the conduct of the study. M. Meier is an employee of Daiichi Sankyo Deutschland GmbH. M. Lamparter is an employee of Daiichi Sankyo Europe GmbH. The work of V. Rudolph and M. Mollenhauer was supported by an unrestricted grant from Daiichi Sankyo. The work of M. Mollenhauer was supported by the Deutsche Forschungsgemeinschaft (MO 3438/2-1) and the Center for Molecular Medicine Cologne (B-12).
: Animal studies in mice with results first presented in this review have been performed by M. Mollenhauer and V. Rudolph. All other animal studies included in this review and performed by any of the authors have been published elsewhere previously. All applicable international, national, and institutional guidelines for the care and use of animals were followed. No studies with human participants were performed for this article. All studies mentioned were in accordance with the ethical standards indicated in each case.